NEW YORK (GenomeWeb News) – Berlin-based RiNA has acquired Roche Applied Science's RTS Protein Expression portfolio of cell-free expression kits for an undisclosed sum, Roche said today.

Under the agreement, which takes effect Sept. 15, the firm 5 Prime will serve as RiNA's distributor for the kits, Roche said.

Manfred Baier, who is head of Roche Applied Science, said in a statement that "a company specializing in proteomics will be able to develop the potential of RTS technology much faster than we can."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.